Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

IRD US Equity

Opus Genetics, Inc.Health Care · Pharmaceutical Preparations · CIK 1228627 · FY ends Dec 31
$4.07
+0.38 (+10.30%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PERCEPTIVE ADVISORS LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Caligan Partners LPsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BALYASNY ASSET MANAGEMENT L.P.sec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-06

Every row is a filed document, checked against its EDGAR index.